北京马力喏生物科技有限公司是致力于肿瘤免疫治疗，特别是结合免疫闸门抑制及CAR-T细胞技术的生物制药公司。公司具有国际一流的研发技术平台，成功开发出系列具有国际专利的抗肿瘤细胞免疫治疗产品，建立起了完善的质量控制体系。主导产品已完成中试，并已在权威医院开展临床试验及转化。
Marino Biotechnology Co,. Ltd is a biotechnology company focused on discovery, research, clinical development and commercialization of cancer immunotherapy based on gene edited engineered CAR-T cells. We strive to develop novel immune-based therapies with potential to utilize the body’s own immune defense system to fight disease while also having the potential to minimize toxicity to normal cells and organ system. Teren brings together world-class immunotherapy researchers, acclaimed scientists and oncologists to develop innovative cancer products based on engineered T cells armed with a Chimeric Antigen Receptor (CAR) to target leukemia and solid tumors, achieves great success, and has a number of related international invention patents.